Academic Journal
The predicted effect and cost-effectiveness of tailoring colonoscopic surveillance according to mismatch repair gene in patients with Lynch syndrome
العنوان: | The predicted effect and cost-effectiveness of tailoring colonoscopic surveillance according to mismatch repair gene in patients with Lynch syndrome |
---|---|
المؤلفون: | Kang, Y-J, Caruana, M, McLoughlin, K, Killen, J, Simms, K, Taylor, N, Frayling, IM, Coupe, VMH, Boussioutas, A, Trainer, AH, Ward, RL, Macrae, F, Canfell, K |
بيانات النشر: | ELSEVIER SCIENCE INC |
سنة النشر: | 2022 |
المجموعة: | The University of Melbourne: Digital Repository |
الوصف: | PURPOSE: Lynch syndrome-related colorectal cancer (CRC) risk substantially varies by mismatch repair (MMR) gene. We evaluated the health impact and cost-effectiveness of MMR gene-tailored colonoscopic surveillance. METHODS: We first estimated sex- and MMR gene-specific cumulative lifetime risk of first CRC without colonoscopic surveillance using an optimization algorithm. Next, we harnessed these risk estimates in a microsimulation model, "Policy1-Lynch," and compared 126 colonoscopic surveillance strategies against no surveillance. RESULTS: The most cost-effective strategy was 3-yearly surveillance from age 25 to 70 years (pathogenic variants [path_] in MLH1 [path_MLH1], path_MSH2) with delayed surveillance for path_MSH6 (age 30-70 years) and path_PMS2 (age 35-70 years) heterozygotes (incremental cost-effectiveness ratio = Australian dollars (A) $8,833/life-year saved). This strategy averted 60 CRC deaths (153 colonoscopies per death averted) over the lifetime of 1000 confirmed patients with Lynch syndrome (vs no surveillance). This also reduced colonoscopies by 5% without substantial change in health outcomes (vs nontailored 3-yearly surveillance from 25-70 years). Generally, starting surveillance at age 25 (vs 20) years was more cost-effective with minimal effect on life-years saved and starting 5 to 10 years later for path_MSH6 and path_PMS2 heterozygotes (vs path_MLH1 and path_MSH2) further improved cost-effectiveness. Surveillance end age (70/75/80 years) had a minor effect. Three-yearly surveillance strategies were more cost-effective (vs 1 or 2-yearly) but prevented 3 fewer CRC deaths. CONCLUSION: MMR gene-specific colonoscopic surveillance would be effective and cost-effective. |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
تدمد: | 1098-3600 1530-0366 |
Relation: | pii: S1098-3600(22)00788-2; Kang, Y. -J., Caruana, M., McLoughlin, K., Killen, J., Simms, K., Taylor, N., Frayling, I. M., Coupe, V. M. H., Boussioutas, A., Trainer, A. H., Ward, R. L., Macrae, F. & Canfell, K. (2022). The predicted effect and cost-effectiveness of tailoring colonoscopic surveillance according to mismatch repair gene in patients with Lynch syndrome. GENETICS IN MEDICINE, 24 (9), pp.1831-1846. https://doi.org/10.1016/j.gim.2022.05.016.; http://hdl.handle.net/11343/322231 |
الاتاحة: | http://hdl.handle.net/11343/322231 |
Rights: | CC BY-NC-ND ; https://creativecommons.org/licenses/by-nc-nd/4.0 |
رقم الانضمام: | edsbas.2A5BF83C |
قاعدة البيانات: | BASE |
تدمد: | 10983600 15300366 |
---|